Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate

Annals of Hematology

Volumn 80, Issue 2, 2001, Pages 119-120

  Neumeister, P ^a,b   Eibl, M ^a   Zinke Cerwenka, W ^a   Scarpatetti, M ^a   Sill, H ^a   Linkesch, W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b Teachers College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBODY CONJUGATE; ANTILEUKEMIC AGENT; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD GROUP ANTIGEN; CALICHEAMICIN DERIVATIVE; CD33 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; DEFIBROTIDE; DISTIGMINE; DIURETIC AGENT; GEMTUZUMAB OZOGAMICIN; HLA ANTIGEN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; ASCITES; AUTOTRANSPLANTATION; CANCER RECURRENCE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; DRUG SPECIFICITY; DRUG TARGETING; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; LEUKEMIA CELL; LEUKEMIA REMISSION; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; MALE; NEUTROPENIA; PARALYTIC ILEUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ACUTE DISEASE; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; IMMUNOTOXINS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; RECURRENCE;

EID: 0035109524     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000239     Document Type: Article

References (11)

1. Antibody-targeted therapy for myeloid leukemia
2. The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia
3. The syndrome of hepatic veno-occlusive disease after marrow transplantation
4. Monoclonal antibodies to the myeloid stem cells: Therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate
5. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia
6. Hematopoietic stem cell markers are expressed by ductal plate and bile duct cells in developing human liver
7. Expression of normal myeloid-associated antigens by acute leukemia cells
8. Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high risk population
9. Treatment of acute myelogenous leukemia in older adults
10. Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate
11. Preliminary results of the efficacy and safety of CMA-676 in patients with AML in first relapse